These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 16417648
1. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer. Pinzon-Charry A, Maxwell T, McGuckin MA, Schmidt C, Furnival C, López JA. Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648 [Abstract] [Full Text] [Related]
2. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients. Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M. Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777 [Abstract] [Full Text] [Related]
3. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Tong AW, Papayoti MH, Netto G, Armstrong DT, Ordonez G, Lawson JM, Stone MJ. Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266 [Abstract] [Full Text] [Related]
4. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency. Gervais A, Levêque J, Bouet-Toussaint F, Burtin F, Lesimple T, Sulpice L, Patard JJ, Genetet N, Catros-Quemener V. Breast Cancer Res; 2005 Mar; 7(3):R326-35. PubMed ID: 15987427 [Abstract] [Full Text] [Related]
5. Cytokines in the generation and maturation of dendritic cells: recent advances. Zou GM, Tam YK. Eur Cytokine Netw; 2002 Mar; 13(2):186-99. PubMed ID: 12101074 [Abstract] [Full Text] [Related]
6. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile. Gelderblom HC, Nijhuis LE, de Jong EC, te Velde AA, Pajkrt D, Reesink HW, Beld MG, van Deventer SJ, Jansen PL. Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933 [Abstract] [Full Text] [Related]
7. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428 [Abstract] [Full Text] [Related]
8. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro. Yano Y, Ueda Y, Itoh T, Fuji N, Okugawa K, Naito K, Imura K, Kohara J, Hayashi T, Nakane K, Matsuura Y, Kawai K, Yamagishi H. Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138 [Abstract] [Full Text] [Related]
9. Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process. Megiovanni AM, Sanchez F, Gluckman JC, Rosenzwajg M. Eur Cytokine Netw; 2004 Jul; 15(2):126-34. PubMed ID: 15319172 [Abstract] [Full Text] [Related]
10. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity. Kim HJ, Kim HO, Lee K, Baek EJ, Kim HS. Vaccine; 2010 Apr 01; 28(16):2877-86. PubMed ID: 20156531 [Abstract] [Full Text] [Related]
11. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity. Naito K, Ueda Y, Itoh T, Fuji N, Shimizu K, Yano Y, Yamamoto Y, Imura K, Kohara J, Iwamoto A, Shiozaki A, Tamai H, Shimizu T, Mazda O, Yamagishi H. Int J Oncol; 2006 Jun 01; 28(6):1481-9. PubMed ID: 16685449 [Abstract] [Full Text] [Related]
12. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients. Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM. Vaccine; 2008 Jun 02; 26(23):2824-32. PubMed ID: 18450338 [Abstract] [Full Text] [Related]
13. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P. Cell Immunol; 2009 Jun 02; 257(1-2):23-31. PubMed ID: 19306994 [Abstract] [Full Text] [Related]
14. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. Dillon SM, Rogers LM, Howe R, Hostetler LA, Buhrman J, McCarter MD, Wilson CC. J Immunol; 2010 Jun 15; 184(12):6612-21. PubMed ID: 20483758 [Abstract] [Full Text] [Related]
15. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Clin Cancer Res; 2003 Jan 15; 9(1):285-94. PubMed ID: 12538481 [Abstract] [Full Text] [Related]
16. [Cytofluorimetric evaluation of peripheral blood dendritic cells in patients with Mediterranean Kaposi's sarcoma]. Vaccari M, Della Bella S, Brambilla L, Ferrucci S, Nicola S, Berti E, Boneschi V, Villa ML. Minerva Med; 2003 Dec 15; 94(6):379-86. PubMed ID: 14976466 [Abstract] [Full Text] [Related]
17. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells. Pietra G, Mortarini R, Parmiani G, Anichini A. Cancer Res; 2001 Nov 15; 61(22):8218-26. PubMed ID: 11719453 [Abstract] [Full Text] [Related]
18. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH. Arthritis Rheum; 2009 Aug 15; 60(8):2304-13. PubMed ID: 19644874 [Abstract] [Full Text] [Related]
19. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks. Kurlander RJ, Tawab A, Fan Y, Carter CS, Read EJ. Transfusion; 2006 Sep 15; 46(9):1494-504. PubMed ID: 16965575 [Abstract] [Full Text] [Related]
20. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells. Holtick U, Marshall SR, Wang XN, Hilkens CM, Dickinson AM. Transplantation; 2008 Mar 15; 85(5):757-66. PubMed ID: 18337671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]